|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 2881 |
FusionGeneSummary for AS3MT_HERC4 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: AS3MT_HERC4 | Fusion gene ID: 2881 | Hgene | Tgene | Gene symbol | AS3MT | HERC4 | Gene ID | 57412 | 26091 |
| Gene name | arsenite methyltransferase | HECT and RLD domain containing E3 ubiquitin protein ligase 4 | |
| Synonyms | CYT19 | - | |
| Cytomap | 10q24.32 | 10q21.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | arsenite methyltransferaseS-adenosyl-L-methionine:arsenic(III) methyltransferaseS-adenosylmethionine:arsenic (III) methyltransferasearsenic (+3 oxidation state) methyltransferasemethylarsonite methyltransferasemethyltransferase cyt19 | probable E3 ubiquitin-protein ligase HERC4HECT domain and RCC1-like domain-containing protein 4HECT-type E3 ubiquitin transferase HERC4hect domain and RLD 4 | |
| Modification date | 20180523 | 20180522 | |
| UniProtAcc | Q9HBK9 | Q5GLZ8 | |
| Ensembl transtripts involved in fusion gene | ENST00000369880, | ENST00000277817, ENST00000412272, ENST00000395198, ENST00000373700, ENST00000395187, ENST00000480158, ENST00000492996, | |
| Fusion gene scores | * DoF score | 3 X 2 X 3=18 | 2 X 2 X 2=8 |
| # samples | 3 | 2 | |
| ** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(2/8*10)=1.32192809488736 | |
| Context | PubMed: AS3MT [Title/Abstract] AND HERC4 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | SARC | TCGA-FX-A76Y-01A | AS3MT | chr10 | 104636792 | + | HERC4 | chr10 | 69716733 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| Frame-shift | ENST00000369880 | ENST00000277817 | AS3MT | chr10 | 104636792 | + | HERC4 | chr10 | 69716733 | - |
| Frame-shift | ENST00000369880 | ENST00000412272 | AS3MT | chr10 | 104636792 | + | HERC4 | chr10 | 69716733 | - |
| Frame-shift | ENST00000369880 | ENST00000395198 | AS3MT | chr10 | 104636792 | + | HERC4 | chr10 | 69716733 | - |
| Frame-shift | ENST00000369880 | ENST00000373700 | AS3MT | chr10 | 104636792 | + | HERC4 | chr10 | 69716733 | - |
| 5CDS-3UTR | ENST00000369880 | ENST00000395187 | AS3MT | chr10 | 104636792 | + | HERC4 | chr10 | 69716733 | - |
| 5CDS-intron | ENST00000369880 | ENST00000480158 | AS3MT | chr10 | 104636792 | + | HERC4 | chr10 | 69716733 | - |
| 5CDS-intron | ENST00000369880 | ENST00000492996 | AS3MT | chr10 | 104636792 | + | HERC4 | chr10 | 69716733 | - |
Top |
FusionProtFeatures for AS3MT_HERC4 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| AS3MT | HERC4 |
| Catalyzes the transfer of a methyl group from AdoMet totrivalent arsenicals producing methylated and dimethylatedarsenicals. It methylates arsenite to form methylarsonate, Me-AsO(3)H(2), which is reduced by methylarsonate reductase tomethylarsonite, Me-As(OH)2. Methylarsonite is also a substrate andit is converted into the much less toxic compound dimethylarsinate(cacodylate), Me(2)As(O)-OH (By similarity). {ECO:0000250}. | Probable E3 ubiquitin-protein ligase involved in eitherprotein trafficking or in the distribution of cellular structures.Required for spermatozoon maturation and fertility, and for theremoval of the cytoplasmic droplet of the spermatozoon. E3ubiquitin-protein ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directlytransfer it to targeted substrates.{ECO:0000250|UniProtKB:Q6PAV2}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for AS3MT_HERC4 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for AS3MT_HERC4 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| AS3MT | RHOU | HERC4 | HERC6, HERC4, UBC, UBE2D2, UBE2E3, UBE2J2, HSP90AA1, C9orf78, DCTPP1, FKBP9, H2AFV, HEXA, NT5C2, PCNA, USP5, WARS, NUBP2, RAD23A, SHMT2, MOV10, NXF1, LSM6, NTRK1, RB1, DNAJC7, BAG3, GMNN, NUF2, UBE2L3, C1orf94, FAM189B, FDXACB1, MOCS3, APOBEC3D, WRAP73, KLHL10, NLRX1, ALOXE3, TRIM25 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for AS3MT_HERC4 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Hgene | AS3MT | Q9HBK9 | DB00118 | Ademetionine | Arsenite methyltransferase | small molecule | approved|investigational|nutraceutical |
Top |
RelatedDiseases for AS3MT_HERC4 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | AS3MT | C0311375 | Arsenic Poisoning | 2 | CTD_human |
| Hgene | AS3MT | C0005612 | Birth Weight | 1 | CTD_human |
| Hgene | AS3MT | C0005695 | Bladder Neoplasm | 1 | CTD_human |
| Hgene | AS3MT | C0027660 | Neoplasms, Glandular and Epithelial | 1 | CTD_human |
| Hgene | AS3MT | C1263846 | Attention deficit hyperactivity disorder | 1 | CTD_human |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|